妊娠35-37周联合筛查子痫前期后的拟定临床管理方案
这项前瞻性观察研究纳入3703例单胎妊娠,在35-37周联合母体特征、病史及MAP、UtA-PI、PlGF、sFlt-1的MoM值计算子痫前期风险,将人群分为高、中、低风险组。高风险组涵盖92%的<40周子痫前期,低风险组无子痫前期发生。
要点
- 35-37周联合筛查可将孕妇分为高、中、低风险三层管理组。
- 高风险组涵盖92%的<40周子痫前期和73%的≥40周子痫前期。
- 低风险组无一例发生<40周或≥40周子痫前期。
核心结论
- 35-37周联合筛查的风险分层旨在识别需从初次评估起至40周密集监测的高风险组、需在40周重新评估的中风险组,以及可 reassured 不太可能发生子痫前期的低风险组。
研究设计与样本
- 前瞻性观察研究,纳入3703例在35-37周接受常规妊娠晚期超声检查的单胎妊娠。
- 采用竞争风险模型,结合母体特征与病史的先验风险及MAP、UtA-PI、PlGF和sFlt-1的MoM值,计算评估后4周内分娩子痫前期和<42周妊娠子痫前期的患者特异性风险。
主要发现
- 研究人群中38例(1.0%)发生<40周妊娠子痫前期,22例(0.6%)发生≥40周妊娠子痫前期。
- 以评估后4周内分娩子痫前期风险1/50为高风险组切点、<42周妊娠子痫前期风险<1/100为低风险组切点,高、中、低风险组比例分别为12.7%、28.8%和58.5%。
- 高风险组包含92%的<40周妊娠子痫前期和73%的≥40周妊娠子痫前期。
- 中风险组另包含27%的≥40周妊娠子痫前期孕妇。
- 低风险组无一例发生<40周或≥40周妊娠子痫前期。
关键数值与推荐
- 高风险组定义:评估后4周内分娩子痫前期风险切点为1/50。
- 低风险组定义:<42周妊娠子痫前期风险切点为<1/100。
- 高、中、低风险组人群比例分别为12.7%、28.8%和58.5%。
临床怎么用
- 高风险组需从初次评估时起至40周妊娠接受密集监测。
- 中风险组需在40周妊娠时重新评估。
- 低风险组可被告知不太可能发生子痫前期。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To estimate the patient-specific risk of pre-eclampsia (PE) at 35-37 weeks' gestation by a combination of maternal characteristics and medical history with multiples of the median (MoM) values of mean arterial pressure (MAP), uterine artery pulsatility index (UtA-PI), serum placental growth factor (PlGF) and serum soluble fms-like tyrosine kinase-1 (sFlt-1), and stratify women into high-, intermediate- and low-risk management groups. METHODS: This was a prospective observational study in women attending a third-trimester ultrasound scan at 35-37 weeks as part of routine pregnancy care. Patient-specific risks of delivery with PE at < 4 weeks from assessment and PE at < 42 weeks' gestation were calculated using the competing-risks model to combine the prior risk from maternal characteristics and medical history with MoM values of MAP, UtA-PI, PlGF and sFlt-1. On the basis of these risks, the population was stratified into high-, intermediate- and low-risk groups. Different risk cut-offs were used to vary the proportion of the population stratified into each risk category and the performance of screening for delivery with PE at < 40 and ≥ 40 weeks' gestation was estimated. RESULTS: The study population of 3703 singleton pregnancies included 38 (1.0%) with PE < 40 weeks' gestation and 22 (0.6%) with PE ≥ 40 weeks. Using a risk cut-off of 1 in 50 for PE delivering at < 4 weeks after assessment to define the high-risk group and a risk cut-off of < 1 in 100 for PE delivering at < 42 weeks' gestation to define the low-risk group, the proportion of the population stratified into high, intermediate and low risk was 12.7%, 28.8% and 58.5%, respectively. The high-risk group contained 92% of pregnancies with PE at < 40 weeks' gestation and 73% of those with PE at ≥ 40 weeks. The intermediate-risk group contained a further 27% of women with PE at ≥ 40 weeks. In the low-risk group, none of the women developed PE at < 40 or ≥ 40 weeks' gestation. CONCLUSION: The study presents risk stratification of PE by the combined test at 35-37 weeks, aiming to identify a high-risk group in need of intensive monitoring from the time of the initial assessment and up to 40 weeks' gestation, an intermediate-risk group in need of reassessment at 40 weeks' gestation and a low-risk group that can be reassured that they are unlikely to develop PE. Copyright © 2017 ISUOG. Published by John Wiley & Sons Ltd.
引用
- Panaitescu AM, Wright D, Militello A, et al. Proposed clinical management of pregnancies after combined screening for pre-eclampsia at 35-37 weeks' gestation. Ultrasound Obstet Gynecol. 2017. PMID: 28133834. doi:10.1002/uog.17419
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。